Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Long-Term Debt Repayments (2018 - 2020)

Neurogene (NGNE) has disclosed Long-Term Debt Repayments for 3 consecutive years, with $2000.0 as the latest value for Q1 2020.

  • For the quarter ending Q1 2020, Long-Term Debt Repayments changed 0.0% year-over-year to $2000.0, compared with a TTM value of $9000.0 through Mar 2020, down 70.0%, and an annual FY2019 reading of $9000.0, down 71.88% over the prior year.
  • Long-Term Debt Repayments was $2000.0 for Q1 2020 at Neurogene, roughly flat from $2000.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $22000.0 in Q3 2018 and bottomed at $2000.0 in Q4 2018.
  • Average Long-Term Debt Repayments over 3 years is $4777.8, with a median of $2000.0 recorded in 2018.
  • Peak annual rise in Long-Term Debt Repayments hit 0.0% in 2019, while the deepest fall reached 86.36% in 2019.
  • Year by year, Long-Term Debt Repayments stood at $2000.0 in 2018, then changed by 0.0% to $2000.0 in 2019, then changed by 0.0% to $2000.0 in 2020.
  • Business Quant data shows Long-Term Debt Repayments for NGNE at $2000.0 in Q1 2020, $2000.0 in Q4 2019, and $3000.0 in Q3 2019.